# Technology for Innovative Monitoring of Cardiovascular Prevention: a RCT

Study · id `cardio:ct-nct03005470` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03005470](<https://clinicaltrials.gov/study/NCT03005470>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03005470

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 231 participants.

## Technical summary

Registry record NCT03005470. Randomized; double masking; primary purpose treatment. Start 2017-01 (registry gives no type); primary completion 2019-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 231 participants (enrolled count; ClinicalTrials.gov record NCT03005470, source copy `cardio:ctgov-nct03005470-2018-04-26`, retrieved 2026-10-26)
- Start date: 2017-01 (registry gives no type) (ClinicalTrials.gov record NCT03005470, source copy `cardio:ctgov-nct03005470-2018-04-26`, retrieved 2026-10-26)
- Primary completion: 2019-02 (anticipated) (ClinicalTrials.gov record NCT03005470, source copy `cardio:ctgov-nct03005470-2018-04-26`, retrieved 2026-10-26)
- Completion: 2019-02 (anticipated) (ClinicalTrials.gov record NCT03005470, source copy `cardio:ctgov-nct03005470-2018-04-26`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT03005470, source copy `cardio:ctgov-nct03005470-2018-04-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03005470-2018-04-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Technology for Innovative Monitoring of Cardiovascular Prevention: a RCT
- Acronym: TIM
- Condition: Blood Pressure, High
- Condition: Prehypertension
- Intervention (Device): TELEM
- Intervention (Device): TELEMEV
- Intervention (Device): TELEM-TELEMEV
- Intervention (Other): UCT
- Lead sponsor: Hospital de Clinicas de Porto Alegre
- Lead sponsor class: OTHER
- Collaborator: Federal University of Rio Grande do Sul
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Hospital de Clinicas de Porto Alegre (`cardio:org-hospital-de-clinicas-de-porto-alegre`)

## Provenance

Content hash: 52f15aacdd1942395adfa214c43a79def3cb38aef731cefda6fa3a3ce5e7572a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
